<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">adair</journal-id><journal-title-group><journal-title xml:lang="ru">Аллергология и Иммунология в Педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Allergology and Immunology in Paediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2500-1175</issn><issn pub-type="epub">2712-7958</issn><publisher><publisher-name>Ассоциация детских аллергологов и иммунологов России</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.53529/2500-1175-2024-2-60-67</article-id><article-id custom-type="elpub" pub-id-type="custom">adair-141</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Целесообразность аллерген-специфической иммунотерапии бронхиальной астмы у детей с полисенсибилизацией</article-title><trans-title-group xml:lang="en"><trans-title>The feasibility of allergen-specific immunotherapy for bronchial asthma in children with polysensitization</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0854-1536</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трусова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Trusova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Трусова Ольга Валерьевна — к. м. н., доцент кафедры терапии госпитальной с курсом аллергологии и иммунологии имени акад. М.В. Черноруцкого с клиникой.</p><p>197022, Санкт-Петербург, ул. Льва Толстого, 6–8</p></bio><bio xml:lang="en"><p>Olga V. Trusova —PhD, assistant professor, department of Therapy with the course on allergy and immunology, Pavlov University.</p><p>197022, St. Petersburg, L. Tolstoy Str., 6–8</p></bio><email xlink:type="simple">o-tru@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9654-3429</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Камаев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kamaev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Камаев Андрей Вячеславович — к. м. н., доцент кафедры общей врачебной практики (семейной медицины).</p><p>197022, Санкт-Петербург, ул. Льва Толстого, 6–8</p></bio><bio xml:lang="en"><p>Andrey V. Kamaev — PhD, assistant professor, department of General Practice (Family Medicine), Pavlov University.</p><p>197022, St. Petersburg, L. Tolstoy Str., 6–8</p></bio><email xlink:type="simple">andykkam@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коростовцев</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Korostovtsev</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Коростовцев Дмитрий Сергеевич — д. м. н., профессор, профессор кафедры педиатрии им. проф. И.М. Воронцова ФП и ДПО.</p><p>194100, Санкт-Петербург, ул. Литовская, 2</p></bio><bio xml:lang="en"><p>Dmitry S. Korostovtsev — DSc, Professor, Department of Pediatrics named after Professor I.M. Vorontsov, Saint Petersburg State Pediatric Medical University.</p><p>194100, St. Petersburg, Litovskaya Str., 2</p></bio><email xlink:type="simple">dsk552@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Federal State Budgetary Educational Institution of Higher Education First St. Petersburg State Medical University named after Academician I.P. Pavlov of the Ministry of Health of the Russian Federation / Pavlov University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Federal State Budgetary Educational Institution of Higher Education St. Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>24</day><month>06</month><year>2024</year></pub-date><volume>0</volume><issue>2</issue><fpage>60</fpage><lpage>67</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Трусова О.В., Камаев А.В., Коростовцев Д.С., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Трусова О.В., Камаев А.В., Коростовцев Д.С.</copyright-holder><copyright-holder xml:lang="en">Trusova O.V., Kamaev A.V., Korostovtsev D.S.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://adair.elpub.ru/jour/article/view/141">https://adair.elpub.ru/jour/article/view/141</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Имеется дефицит исследований, которые бы оценивали эффективность аллерген-специфической иммунотерапии (АСИТ) у детей с бронхиальной астмой (БА) и полисенсибилизацией.</p></sec><sec><title>Цель исследования</title><p>Цель исследования: оценить эффективность аллерген-специфической иммунотерапии с аллергенами клещей домашней пыли (КДП) в лечении бронхиальной астмы у детей, полисенсибилизированных к круглогодичным аллергенам, на основании динамики индекса симптомов и препаратов.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В открытое проспективное контролируемое исследование в рамках повседневной клинической практики включили 36 детей в возрасте 9,6 [6,9; 12,3] года с атопической БА средней (21 ребенок, 58%) и легкой (15 детей, 42%) степени тяжести и полисенсибилизацией к бытовым аллергенам.</p><p>Каждый пациент наблюдался в исследовании в течение 4 лет: 1 год предварительного наблюдения и 3 года проведения сублингвальной АСИТ аллергенами D. pteronyssinus, D. farinae (Staloral аллерген клещей, Stallergenes Greer, Франция). За каждый год наблюдения проводили оценку симптомов БА и используемых медикаментов, рассчитывали индекс симптомов и использования препаратов. Для подтверждения сенсибилизации выполняли прик-тест по стандартной методике с аллергенами: домашняя пыль, D. pteronyssinus, D. farinae, шерсть кошки, шерсть собаки, перхоть лошади, перо подушки («Биомед», Россия).</p></sec><sec><title>Результаты</title><p>Результаты. За 2 года проведения АСИТ снижение общего индекса симптомов и препаратов составило 46,9%, а по окончании 3 лет терапии 59,8% (р = 0,0001 от исходного). Снижение общего индекса симптомов и препаратов, превышающее 34,9% в сравнении с исходным, отмечено у всех пациентов в исследовании.</p></sec><sec><title>Заключение</title><p>Заключение. Сублингвальная АСИТ аллергенами КДП высоко эффективна в лечении БА и АР у детей с бытовой полисенсибилизацией, в отношении снижения симптомов заболевания, потребности в препаратах фармакотерапии и общего индекса симптомов и препаратов.</p><p>Значимый положительный эффект регистрируется уже с первого года АСИТ и продолжает усиливаться на протяжении последующих лет терапии.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Relevance</title><p>Relevance. There is a shortage of studies that would evaluate the effectiveness of allergen immunotherapy (AIT) in children with bronchial asthma (BA) and polysensitization.</p></sec><sec><title>The aim of the study</title><p>The aim of the study: to evaluate AIT effectiveness with house dust mite (HDM) allergens in the treatment of BA in children polysensitized to perennial allergens, based on the dynamics of the symptoms and medications score.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The open prospective controlled study included 36 children aged 9,6 [6,9; 12,3] years (from 6 years 1 months to 14 years 3 months) with moderate atopic asthma (21 children (58%) and mild asthma (15 children (42%) and polysensitization to household allergens. Each patient was observed in the study for 4 years: 1 year of preliminary observation and 3 years of sublingual AIT with D. pteronyssinus and D. farinae (Staloral, Stallergenes Greer, France). For each year of observation, asthma symptoms and medications used were assessed, and the combined Score was calculated. To confirm sensitization, a prick test was performed using a standard method with allergens: house dust, D. pteronyssinus, D. farinae, cat, dog, horse, pillow feather (Biomed, Russia).</p></sec><sec><title>Results</title><p>Results. Over 2 years of AIT, the decrease in the symptom and medication Score was 46,9%, and at the end of 3rd year of therapy, 59,8% (р = 0,0001 from baseline). A decrease in the combined Score exceeding 34.9% compared to baseline was noted in all patients in the study.</p></sec><sec><title>Conclusion</title><p>Conclusion. Sublingual AIT with HDM allergens is highly effective in the treatment of asthma in children with domestic polysensitization, in terms of reducing symptoms of the disease, the need for pharmacotherapy and the combined Score of symptoms and medications. A significant positive effect was registered already from the first year of AIT and continues to increase over subsequent years of therapy.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>бронхиальная астма</kwd><kwd>аллерген-специфическая иммунотерапия</kwd><kwd>полисенсибилизация</kwd><kwd>клещи домашней пыли</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>bronchial asthma</kwd><kwd>allergen immunotherapy</kwd><kwd>polysensitization</kwd><kwd>house dust mites</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Passalacqua G, Bagnasco D, Canonica GW. 30 years of sublingual immunotherapy. Allergy. 2020; 75: 1107–1120. https://doi.org/10.1111/all.14113.</mixed-citation><mixed-citation xml:lang="en">Passalacqua G, Bagnasco D, Canonica GW. 30 years of sublingual immunotherapy. Allergy. 2020; 75: 1107–1120. https://doi.org/10.1111/all.14113.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">de Blay F, Gherasim A, Casale TB et al. Which patients with asthma are most likely to benefit from allergen immunotherapy? J Allergy Clin Immunol. 2022; 149 (3): 833–843. https://doi.org/10.1016/j.jaci.2022.01.011.</mixed-citation><mixed-citation xml:lang="en">de Blay F, Gherasim A, Casale TB et al. Which patients with asthma are most likely to benefit from allergen immunotherapy? J Allergy Clin Immunol. 2022; 149 (3): 833–843. https://doi.org/10.1016/j.jaci.2022.01.011.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Alvaro-Lozano M, Akdis CA, Akdis M et al. EAACI Allergen Immunotherapy User’s Guide. Pediatr Allergy Immunol. 2020; 31, Suppl. 25: 1–101. https://doi.org/10.1111/pai.13189.</mixed-citation><mixed-citation xml:lang="en">Alvaro-Lozano M, Akdis CA, Akdis M et al. EAACI Allergen Immunotherapy User’s Guide. Pediatr Allergy Immunol. 2020; 31, Suppl. 25: 1–101. https://doi.org/10.1111/pai.13189.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zemelka-Wiacek M, Agache I, Akdis CA et al. Hot topics in allergen immunotherapy, 2023: Current status and future perspective. Allergy. 2024; 79: 823–842. https://doi.org/10.1111/all.15945.</mixed-citation><mixed-citation xml:lang="en">Zemelka-Wiacek M, Agache I, Akdis CA et al. Hot topics in allergen immunotherapy, 2023: Current status and future perspective. Allergy. 2024; 79: 823–842. https://doi.org/10.1111/all.15945.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pfaar O, Bousquet J, Durham S et al. One hundred and ten years of allergen immunotherapy: A journey from empiric observation to evidence. Allergy. 2022; 77 (2): 454–468. https://doi.org/10.1111/all.15023.</mixed-citation><mixed-citation xml:lang="en">Pfaar O, Bousquet J, Durham S et al. One hundred and ten years of allergen immunotherapy: A journey from empiric observation to evidence. Allergy. 2022; 77 (2): 454–468. https://doi.org/10.1111/all.15023.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bahceciler NN, Yuruker O. Planning and approach to allergen-specific immunotherapy in polyallergic patients. Immunotherapy. 2020; 12 (8): 577–585. https://doi.org/10.2217/imt-2019-0182.</mixed-citation><mixed-citation xml:lang="en">Bahceciler NN, Yuruker O. Planning and approach to allergen-specific immunotherapy in polyallergic patients. Immunotherapy. 2020; 12 (8): 577–585. https://doi.org/10.2217/imt-2019-0182.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ciprandi G, Alesina R, Ariano R et al. Characteristics of patients with allergic polysensitization: the POLISMAIL study. Eur Ann Allergy Clin Immunol. 2008; 40: 77–83.</mixed-citation><mixed-citation xml:lang="en">Ciprandi G, Alesina R, Ariano R et al. Characteristics of patients with allergic polysensitization: the POLISMAIL study. Eur Ann Allergy Clin Immunol. 2008; 40: 77–83.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang YZ, Luo J, Wang ZH, Wang J. Efficacy and safety of sublingual dust mite drops in children with mono- or polysensitized allergic rhinitis. Am J Otolaryngol. 2019; 40 (5): 755–760. https://doi.org/10.1016/j.amjoto.2019.07.010.</mixed-citation><mixed-citation xml:lang="en">Zhang YZ, Luo J, Wang ZH, Wang J. Efficacy and safety of sublingual dust mite drops in children with mono- or polysensitized allergic rhinitis. Am J Otolaryngol. 2019; 40 (5): 755–760. https://doi.org/10.1016/j.amjoto.2019.07.010.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Phinyo P, Krikeerati T, Wongyikul P et al. House dust mite allergen immunotherapy for monosensitized versus polysensitized patients with allergic rhinitis: A systematic review and meta-analysis. Asian Pac J Allergy Immunol. 2022; 40 (4): 337–352. https://doi.org/10.12932/ap-190822-1440.</mixed-citation><mixed-citation xml:lang="en">Phinyo P, Krikeerati T, Wongyikul P et al. House dust mite allergen immunotherapy for monosensitized versus polysensitized patients with allergic rhinitis: A systematic review and meta-analysis. Asian Pac J Allergy Immunol. 2022; 40 (4): 337–352. https://doi.org/10.12932/ap-190822-1440.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Трусова ОВ, Камаев АВ, Ляшенко НЛ, Макарова ИВ. Клинико-анамнестические характеристики и результаты аллергологического обследования у детей с бронхиальной астмой и аллергическим ринитом при аллергии на клещей домашней пыли. Аллергология и иммунология в педиатрии. 2021; 3 (66): 40–48. https://doi.org/10.53529/2500-1175-2021-3-40-48.</mixed-citation><mixed-citation xml:lang="en">Trusova OV, Kamaev AV, Lyashenko NL, Makarova IV. Clinical and anamnestic characteristics and results of allergological testing in children with bronchial asthma and allergic rhinitis in case of allergy to house dust mites. Allergology and Immunology in Pediatrics. 2021; 3 (66): 40–48. (In Russ.) https://doi.org/10.53529/2500-1175-2021-3-40-48.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dhami S, Kakourou A, Asamoah F et al. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy. 2017; 72: 1825–1848. https://doi.org/10.1111/all.13208.</mixed-citation><mixed-citation xml:lang="en">Dhami S, Kakourou A, Asamoah F et al. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy. 2017; 72: 1825–1848. https://doi.org/10.1111/all.13208.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Инструкция по применению лекарственного препарата для медицинского применения Сталораль «Аллерген клещей» капли подъязычные. URL: https://cdn.pharm-portal.ru/69jxs7cjr4n4gdc2acy5y4x8/instructions/%D0%9B%D0%A1%D0%A0-008340_10/InstrImg_2021_4_1_1467743/%D0%9B%D0%A1%D0%A0-008340_10[2021]_4.pdf. Ссылка активна на 05.03.2023.</mixed-citation><mixed-citation xml:lang="en">Инструкция по применению лекарственного препарата для медицинского применения Сталораль «Аллерген клещей» капли подъязычные. URL: https://cdn.pharm-portal.ru/69jxs7cjr4n4gdc2acy5y4x8/instructions/%D0%9B%D0%A1%D0%A0-008340_10/InstrImg_2021_4_1_1467743/%D0%9B%D0%A1%D0%A0-008340_10[2021]_4.pdf. Ссылка активна на 05.03.2023.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Трусова ОВ, Камаев АВ, Трофимов ВИ, Макарова ИВ. Оценка клинической эффективности аллерген-специфической терапии с аллергенами клещей домашней пыли у пациентов с бронхиальной астмой с помощью индекса симптомов и препаратов. Практическая пульмонология. 2020; 4: 10–15.</mixed-citation><mixed-citation xml:lang="en">Trusova OV, Kamaev AV, Trofimov VI, Makarova IV. The assessment of clinical efficacy of allergen-specific therapy with house dust mite allergens in patients with asthma using symptom index and drugs. Prakticheskaya pulmonologiya. 2020; 4: 10–15. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bousquet J, Heinzerling L, Bachert C et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012; 67: 18–24. https://doi.org/10.1111/j.1398-9995.2011.02728.x.</mixed-citation><mixed-citation xml:lang="en">Bousquet J, Heinzerling L, Bachert C et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012; 67: 18–24. https://doi.org/10.1111/j.1398-9995.2011.02728.x.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang AZ, Liang ME, Chen XX et al. Clinical Evaluation for Sublingual Immunotherapy With Dermatophagoides farinae in Polysensitized Allergic Asthma Patients. Front Med (Lausanne). 2021; 8: 645356.</mixed-citation><mixed-citation xml:lang="en">Zhang AZ, Liang ME, Chen XX et al. Clinical Evaluation for Sublingual Immunotherapy With Dermatophagoides farinae in Polysensitized Allergic Asthma Patients. Front Med (Lausanne). 2021; 8: 645356.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts G, Pfaar O, Akdis CA et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018; 73: 765–798. https://doi.org/10.1111/all.13317.</mixed-citation><mixed-citation xml:lang="en">Roberts G, Pfaar O, Akdis CA et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018; 73: 765–798. https://doi.org/10.1111/all.13317.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pfaar O, Bachert C, Bufe A et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Allergo J Int. 2014; 23 (8): 282–319. https://doi.org/10.1007/s40629-014-0032-2.</mixed-citation><mixed-citation xml:lang="en">Pfaar O, Bachert C, Bufe A et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Allergo J Int. 2014; 23 (8): 282–319. https://doi.org/10.1007/s40629-014-0032-2.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
